Tag: Liberty Leaf - Psilocybin Alpha

New Resource: Psychedelic Legalization & Decriminalization Tracker

Liberty Leaf to Acquire Nova Mentis Biotech Corp. – Liberty Leaf Augments Portfolio with Entrance into the Emerging Psilocybin Therapy Market

Post published:June 22, 2020
Post category:Press Release

End of content

No more pages to load

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Psychedelic Stocks and Companies
News & Interviews
Psychedelic Sector Jobs
Data Bank

Industry insights and interviews delivered to your inbox. No spam, just valuable information.

Psychedelic Sector Overview

Explore the Psychedelic Sector Landscape visually using our new tool.

Psychedelics Patent Trackers

We track the latest patents and filings related to psilocybin, MDMA and DMT.

Psychedelic Legalization & Decriminalization Tracker

Mapping psychedelic drug policy reform across the United States

Psychedelics Drug Development Tracker

From drug discovery to regulatory approval, we map drug development in psychedelics.

How to Buy Psychedelic Stocks

Looking to invest in psychedelics? This handy guide explains how to buy stocks and shares outside of Canada.

Liberty Leaf to Acquire Nova Mentis Biotech Corp. – Liberty Leaf Augments Portfolio with Entrance into the Emerging Psilocybin Therapy Market

Psilocybin Alpha

Quick Links

Newsletter

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.